quinazolines has been researched along with Testicular Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, Q; Ji, J; Li, BB; Tong, XH; Wu, XX; Zhang, XY | 1 |
Casanovas, O; Castillo-Ávila, W; Condom, E; Garcia Del Muro, X; Germà, JR; Graupera, M; Hernández-Losa, J; Juliachs, M; Pandiella, A; Piulats, JM; Teixidó, C; Vidal, A; Villanueva, A; Viñals, F | 1 |
Aherne, GW; Hardcastle, A; Jackman, AL; Kelland, LR; Kimbell, R | 1 |
Brunstrom, G; Hiorns, LR; Kelland, LR; Leyland-Jones, B; Newlands, ES; Paradinas, F; Seckl, MJ; Sharp, SY; Skelton, LA | 1 |
4 other study(ies) available for quinazolines and Testicular Neoplasms
Article | Year |
---|---|
[Gefitineb inhibits the growth and induces the apoptosis of mouse I-10 Leydig testicular cancer cells in vitro].
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Gefitinib; Leydig Cell Tumor; Male; Mice; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Quinazolines; Testicular Neoplasms | 2015 |
ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Blotting, Western; Carcinoma, Embryonal; Cell Survival; Cetuximab; Choriocarcinoma; Endodermal Sinus Tumor; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Immunoprecipitation; Lapatinib; Male; Mice; Mice, Nude; Neoplasms, Experimental; Neoplasms, Germ Cell and Embryonal; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Real-Time Polymerase Chain Reaction; Receptor, ErbB-2; Receptor, ErbB-3; Teratocarcinoma; Testicular Neoplasms; Transplantation, Heterologous | 2013 |
Relationships between resistance to cisplatin and antifolates in sensitive and resistant tumour cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance; Female; Folic Acid; Folic Acid Antagonists; Humans; Male; Ovarian Neoplasms; Quinazolines; Testicular Neoplasms; Thiophenes; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1995 |
A molecular cytogenetic approach to studying platinum resistance.
Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosomes, Human; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; In Situ Hybridization; In Situ Hybridization, Fluorescence; Male; Organoplatinum Compounds; Platinum Compounds; Quinazolines; Testicular Neoplasms; Tumor Cells, Cultured | 1999 |